--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About AVXL20260417C5
Pharmaceutical
Anavex Life Sciences Corp., founded on January 23, 2004, is located in Nevada. Is a clinical-stage biopharmaceutical company dedicated to the development of differentiated therapies that apply precision medicine to central nervous system (CNS) diseases with high unmet needs. The company's focus is on developing innovative therapies for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative diseases, rare diseases including Rett syndrome, and other central nervous system (CNS) diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
